esketamine;postoperative nausea and vomiting;bariatric surgery

The effect of ketamine on postoperative nausea and vomiting in obese patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400090776

Enrollment

Unknown

Registered

2024-10-12

Start date

2024-10-12

Completion date

Unknown

Last updated

2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity

Interventions

1:Induction of ketamine and postoperative analgesia

2:Induction of sufentanil and postoperative analgesia

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ? Age : 18-65 years old.? ASA: II-III.?BMI = 30 kg/m2.? Patients who undergo elective laparoscopic sleeve gastrectomy and choose to use an analgesic pump after surgery.? APFEL score = 2

Exclusion criteria

Exclusion criteria: ? Allergic to any medication used in the study.? Known glaucoma, hyperthyroidism or pheochromocytoma, grade III hypertension (extremely high risk), severe arrhythmia, severe cardiovascular and cerebrovascular disease, or hemodynamic instability.? Severe liver and kidney dysfunction.? Preoperative use of sedatives or analgesics (any sedative hypnotic drugs such as benzodiazepines and non benzodiazepine receptor agonists or opioid drugs such as morphine, fentanyl, and hydrocodone).? Refusal to provide informed consent or inability to collaborate with researchers

Design outcomes

Primary

Measure	Time frame
postoperative nausea and vomiting;	—

Countries

China

Contacts

Public ContactLinJiang

Taizhou People's Hospital

jianglin@njmu.edu.cn+86 151 6106 1166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026